Dimensional Fund Advisors LP Kura Oncology, Inc. Transaction History

Dimensional Fund Advisors LP

  • $418 Billion
  • Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,242,932 shares of KURA stock, worth $12.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,242,932
Previous 1,362,424 8.77%
Holding current value
$12.2 Million
Previous $8.99 Million 20.24%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$5.55 - $6.92 $663,180 - $826,884
-119,492 Reduced 8.77%
1,242,932 $7.17 Million
Q1 2025

May 13, 2025
SELL
$6.6 - $9.05 $419,337 - $575,000
-63,536 Reduced 4.46%
1,362,424 $8.99 Million
Q4 2024

Feb 13, 2025
BUY
$8.51 - $19.21 $3.17 Million - $7.15 Million
372,196 Added 35.32%
1,425,960 $12.4 Million
Q3 2024

Nov 07, 2024
BUY
$18.57 - $23.23 $2.96 Million - $3.7 Million
159,145 Added 17.79%
1,053,764 $20.6 Million
Q2 2024

Aug 09, 2024
SELL
$17.53 - $22.98 $8.22 Million - $10.8 Million
-468,816 Reduced 34.38%
894,619 $18.4 Million
Q1 2024

May 10, 2024
SELL
$13.42 - $23.53 $8.57 Million - $15 Million
-638,319 Reduced 31.89%
1,363,435 $29.1 Million
Q4 2023

Feb 07, 2024
BUY
$7.58 - $14.38 $1.5 Million - $2.84 Million
197,530 Added 10.95%
2,001,754 $28.8 Million
Q3 2023

Nov 09, 2023
SELL
$8.44 - $11.86 $906,726 - $1.27 Million
-107,432 Reduced 5.62%
1,804,224 $16.5 Million
Q2 2023

Aug 09, 2023
BUY
$9.62 - $13.99 $736,622 - $1.07 Million
76,572 Added 4.17%
1,911,656 $20.2 Million
Q1 2023

May 12, 2023
BUY
$10.71 - $14.6 $1.43 Million - $1.96 Million
133,912 Added 7.87%
1,835,084 $22.4 Million
Q4 2022

Feb 09, 2023
BUY
$11.23 - $16.9 $1.44 Million - $2.17 Million
128,515 Added 8.17%
1,701,172 $21.1 Million
Q3 2022

Nov 10, 2022
BUY
$12.01 - $19.45 $2.32 Million - $3.75 Million
193,042 Added 13.99%
1,572,657 $21.5 Million
Q2 2022

Aug 12, 2022
BUY
$10.71 - $18.33 $3.31 Million - $5.66 Million
308,930 Added 28.85%
1,379,615 $25.3 Million
Q1 2022

May 13, 2022
BUY
$11.78 - $16.98 $3.49 Million - $5.03 Million
296,175 Added 38.24%
1,070,685 $17.2 Million
Q4 2021

Feb 09, 2022
BUY
$12.22 - $19.57 $1.52 Million - $2.43 Million
124,269 Added 19.11%
774,510 $10.8 Million
Q3 2021

Nov 12, 2021
SELL
$15.42 - $21.72 $1.7 Million - $2.39 Million
-110,066 Reduced 14.48%
650,241 $12.2 Million
Q2 2021

Aug 12, 2021
SELL
$20.85 - $29.88 $1.23 Million - $1.76 Million
-58,785 Reduced 7.18%
760,307 $15.9 Million
Q1 2021

May 14, 2021
BUY
$24.75 - $39.14 $4.22 Million - $6.68 Million
170,582 Added 26.3%
819,092 $23.1 Million
Q4 2020

Feb 25, 2021
BUY
$29.0 - $41.62 $18.8 Million - $27 Million
648,510 New
648,510 $21.2 Million

Others Institutions Holding KURA

# of Institutions
190
Shares Held
79.8M
Call Options Held
53.6K
Put Options Held
42.8K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $659M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email